Carmel Judith Hillyard
Idexx Laboratories
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carmel Judith Hillyard.
Journal of Immunological Methods | 1994
Glenn G. Lilley; Olan Dolezal; Carmel Judith Hillyard; Claude C. A. Bernard; Peter J. Hudson
Recombinant single chain Fv (scFv) antibody fragments can form the basis of a rapid, whole-blood diagnostic assay. The scFv described in this study is derived from a monoclonal antibody which has a high affinity for glycophorin A, an abundant glycoprotein on the human red blood cell membrane surface. The prototype reagent built around the scFv was designed to detect, in whole blood samples, the presence of antibodies that have arisen through infection with a foreign organism such as human immunodeficiency virus. The scFv was composed of the antibody heavy-chain variable domain (Vh) joined by a 15 residue linker -(GGGGS)3- to the light-chain variable domain (V1) terminated by either a C-terminal octapeptide tail (FLAG) or a 35 amino acid segment from the gp41 surface glycoprotein of HIV-1. Constructs were cloned into a Escherichia coli expression vector, pHFA, and expressed in a soluble form into culture supernatant. The product retained anti-glycophorin activity which could be detected directly in culture supernatants by ELISA. Furthermore, the scFv-epitope fusion functioned efficiently in the whole blood agglutination assay and was able to distinguish between HIV-1 positive and negative sera.
Journal of Immunological Methods | 1991
Kim Wilson; Michael Gerometta; Dennis B. Rylatt; Peter Gregory Bundesen; Dale A. McPhee; Carmel Judith Hillyard; Bruce E. Kemp
A rapid whole blood test has been developed for circulating antibodies to human immunodeficiency virus type 1 (HIV-1), based on agglutination of autologous red blood cells. Evaluation of the test revealed that 100% of seropositive HIV-1 patients (both asymptomatic and AIDS cases) were detected (n = 94) with a specificity of 99.5% in healthy blood donors (n = 596). The assay uses an Fab fragment of a monoclonal antibody specifically directed against glycophorin (a transmembrane glycoprotein present on the surface of human red blood cells). This anti-red blood cell Fab is conjugated via the inter-heavy chain cysteines to a synthetic peptide corresponding to the immunodominant epitope of the HIV-1 viral coat protein gp41 (579-613). Addition of this reagent to 10 microliters of whole blood results in the Fab-peptide conjugate coating the red blood cells with peptide. In the presence of circulating antibodies to the HIV-1 peptide, red cell agglutination occurs within 2 min. The sensitivity and specificity of this reagent indicate that it is appropriate for use as a rapid diagnostic test for HIV-1 seropositivity.
Archive | 1988
Carmel Judith Hillyard; Dennis B. Rylatt; Bruce Ernest Kemp; Peter Gregory Bundesen
Archive | 1992
Bruce Ernest Kemp; Carmel Judith Hillyard; Dennis B. Rylatt; Peter Gregory Bundesen
Archive | 1993
Paul R. Eisenberg; Dennis B. Rylatt; Carmel Judith Hillyard; Peter Gregory Bundesen
Archive | 1993
Glenn G. Lilley; Peter John Hudson; Carmel Judith Hillyard
Archive | 2005
Benjamin Ward Muir; Michaael C. Barden; Dennis B. Rylatt; Joe Nobuyoshi Maeji; Carmel Judith Hillyard; Alain-Dominique Gorse; Raisa Leonidovna Monteiro
Archive | 1990
Peter Gregory Bundesen; Dennis B. Rylatt; Carmel Judith Hillyard
Archive | 2005
Benjamin Ward Muir; Michael C. Barden; Dennis B. Rylatt; N. Joe Maeji; Carmel Judith Hillyard; Alain-Dominique Gorse
Archive | 1993
Glenn G. Lilley; Peter John Hudson; Carmel Judith Hillyard
Collaboration
Dive into the Carmel Judith Hillyard's collaboration.
Commonwealth Scientific and Industrial Research Organisation
View shared research outputs